Literature DB >> 16438645

Mycobacterium tuberculosis upregulates coreceptors CCR5 and CXCR4 while HIV modulates CD14 favoring concurrent infection.

Adrián G Rosas-Taraco1, Alma Y Arce-Mendoza, Guillermo Caballero-Olín, Mario C Salinas-Carmona.   

Abstract

Tuberculosis is the most frequent coinfection in humans infected with HIV-1, but little is known about mechanisms that favors coinfection. The aim of this work is to understand tuberculosis and HIV infections. We determined the pattern of expression of CD11c, CD14, CD40, CCR5, and CXCR4 and quantified IL-1beta, IL-6, IL-8, TNF-alpha, and RANTES in tuberculosis patients and HIV patients. Monocytes from healthy PPD+ volunteers (HP(+)V) stimulated with intracellular proteins (IP), lipids, and polysaccharides (PLS) from Mycobacterium tuberculosis down regulate CD11c expression (p < 0.05). On the contrary, CD14 expression was elevated in tuberculosis patients (p < 0.05) and HIV-infected patients (p > 0.05). CD14 expression was elevated on monocytes from HP(+)V stimulated with PLS and lipids (p < 0.05). CD40 low expression was found in tuberculosis patients and on monocytes from HP(+)V stimulated with lipids, but it was elevated in HIV-infected patients (p < 0.05). CXCR4 and CCR5 expression was high in pulmonary tuberculosis patients and low in HIV-infected patients (p < 0.05). Finally, CCR5+ monocytes from HP(+)V after stimulation with PLS and CXCR4+ lymphocytes were elevated after stimulation with IP (p < 0.05). In general, high levels of IL-1beta, IL-6, and TNF-alpha were found in all groups, but low levels of RANTES were found in pulmonary tuberculosis patients. In conclusion, the pulmonary tuberculosis patients have a microenvironment that facilitates the HIV infection through three possible mechanisms: (1) increasing the coreceptor for HIV entrance, (2) increasing proinflammatory cytokines, and (3) down-regulating RANTES. At the same time, HIV patients have a microenvironment that facilitates entry of M. tuberculosis into macrophages through CD14.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16438645     DOI: 10.1089/aid.2006.22.45

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  17 in total

Review 1.  Tuberculosis and HIV Coinfection.

Authors:  Judith Bruchfeld; Margarida Correia-Neves; Gunilla Källenius
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-26       Impact factor: 6.915

2.  Model-based evaluation of the pharmacokinetic differences between adults and children for lopinavir and ritonavir in combination with rifampicin.

Authors:  Chao Zhang; Paolo Denti; Eric H Decloedt; Yuan Ren; Mats O Karlsson; Helen McIlleron
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

Review 3.  Immunology of Mycobacterium tuberculosis Infections.

Authors:  Jonathan Kevin Sia; Jyothi Rengarajan
Journal:  Microbiol Spectr       Date:  2019-07

Review 4.  Chemokines shape the immune responses to tuberculosis.

Authors:  Samantha R Slight; Shabaana A Khader
Journal:  Cytokine Growth Factor Rev       Date:  2012-11-16       Impact factor: 7.638

5.  Construction and analysis of the transcription factor-microRNA co-regulatory network response to Mycobacterium tuberculosis: a view from the blood.

Authors:  Yan Lin; Zipeng Duan; Feng Xu; Jiayuan Zhang; Marina V Shulgina; Fan Li
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

6.  The burden and characteristics of tuberculosis/human immunodeficiency virus (TB/HIV) in South Korea: a study from a population database and a survey.

Authors:  Chang-Hoon Lee; Ji-Young Hwang; Dae-Kyu Oh; Mee-Kyung Kee; Eunjung Oh; Jung-Wook An; Jinhyun Kim; Heonsook Do; Hee-Jin Kim; Sung Soon Kim; Hwahyun Kim; Jeong-Gu Nam
Journal:  BMC Infect Dis       Date:  2010-03-12       Impact factor: 3.090

Review 7.  Chronic Immune Activation in TB/HIV Co-infection.

Authors:  Riti Sharan; Allison N Bucşan; Shashank Ganatra; Mirko Paiardini; Mahesh Mohan; Smriti Mehra; Shabaana A Khader; Deepak Kaushal
Journal:  Trends Microbiol       Date:  2020-04-22       Impact factor: 17.079

8.  HIV testing, HIV status and outcomes of treatment for tuberculosis in a major diagnosis and treatment centre in Yaounde, Cameroon: a retrospective cohort study.

Authors:  Eric Walter Pefura Yone; Christopher Kuaban; André Pascal Kengne
Journal:  BMC Infect Dis       Date:  2012-08-15       Impact factor: 3.090

Review 9.  Tuberculosis and HIV co-infection.

Authors:  Andrzej Pawlowski; Marianne Jansson; Markus Sköld; Martin E Rottenberg; Gunilla Källenius
Journal:  PLoS Pathog       Date:  2012-02-16       Impact factor: 6.823

Review 10.  Multifaceted Impact of Host C-C Chemokine CCL2 in the Immuno-Pathogenesis of HIV-1/M. tuberculosis Co-Infection.

Authors:  A Wahid Ansari; Adeeba Kamarulzaman; Reinhold E Schmidt
Journal:  Front Immunol       Date:  2013-10-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.